Presenting on "Anti-NGF monoclonal antibodies for the treatment of chronic pain" in a Joint Plenary Lecture with the European Headache Federation (EHF)

Martin Schmelz is director of the Dept. of Experimental Pain Research at the Medical Faculty Mannheim, Heidelberg University and as neurophysiologist focused on translational aspects of itch and pain. His focus in on sensitization of primary afferents recording from experimental animals, volunteers and patients spanning a period of 30 years (H-factor >70). Key research questions are mechanisms of ongoing activity and sensitization of nociceptors. He is a former president of the German IASP chapter and has been spokesperson for German collaborative research groups on pain and itch.